MACQUARIE GROUP LTD - SURFACE ONCOLOGY INC ownership

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of SURFACE ONCOLOGY INC
ValueSharesWeighting
Q2 2023$304,000
+24.1%
350,0000.0%0.00%
Q1 2023$245,000
-14.6%
350,0000.0%0.00%
Q4 2022$287,000
-21.2%
350,0000.0%0.00%
Q3 2022$364,000
-36.6%
350,0000.0%0.00%
-100.0%
Q2 2022$574,000
-44.2%
350,0000.0%0.00%0.0%
Q1 2022$1,029,000
-38.5%
350,0000.0%0.00%0.0%
Q4 2021$1,673,000
-36.9%
350,0000.0%0.00%
-50.0%
Q3 2021$2,650,000
+1.5%
350,0000.0%0.00%0.0%
Q2 2021$2,611,000
-4.4%
350,0000.0%0.00%
-50.0%
Q1 2021$2,730,000
-15.6%
350,0000.0%0.00%
-20.0%
Q4 2020$3,234,000350,0000.01%
Other shareholders
SURFACE ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 2,945,453$22,297,0007.41%
ACT CAPITAL MANAGEMENT, LLC 170,500$1,291,0000.67%
SummerHaven Investment Management, LLC 128,078$970,0000.57%
Parkman Healthcare Partners LLC 248,267$1,879,0000.48%
SILVERARC CAPITAL MANAGEMENT, LLC 50,000$379,0000.21%
C M BIDWELL & ASSOCIATES LTD 33,030$250,0000.17%
ARK Investment Management 4,618,354$34,961,0000.08%
Knights of Columbus Asset Advisors LLC 114,594$867,0000.08%
Orbimed Advisors 909,666$6,886,0000.08%
HighVista Strategies LLC 13,932$105,0000.07%
View complete list of SURFACE ONCOLOGY INC shareholders